Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation ...

Illumina first flagged the deal in June 2025 as part of a strategy to bolt protein readouts onto its sequencing ecosystem, according to Illumina. The seller, Standard BioTools, said it has now ...

Pangea Laboratory collaborates with Gene Solutions to advance cancer diagnostics in United States: Irvine, California Saturday, January 24, 2026, 12:00 Hrs [IST] Pangea Laboratory ...

Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation ...

Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today announced a strategic collaboration with Gene ...

Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Combining virtual dental care with licensed dentists and an innovative oral cancer diagnostics solution ensures all ...

New AI-derived model integrates longitudinal ctDNA and clinical data with digital pathology and tumor sequencing data, to refine recurrence risk assessment and outcomes predictionAUSTIN, ...